RenovoRx Advances Commercialization of RenovoCath® with Several New Purchase Orders, Including Customer Reorders
RenovoRx today announced continuing momentum with the Company’s RenovoCath commercial strategy, with new purchase orders received from several esteemed, high volume National Cancer Institute-designated centers.